dihexa molecular formula | 1401708-83-5 | BGC70883 Dihexa 5MG Research Material |

Industry Response: The compounding pharmacy industry, medical practitioners, and patient advocacy groups pushed back against the Category 2 classification, arguing that the safety data did not support such a restrictive designation

Manage weight or body composition shifts: Ask your healthcare professional about proven treatments like GLP-1s, berberine, or targeted nutrition and lifestyle strategies

Experimental work has shown that cagrilintide lowers body weight through brain amylin receptors, especially receptor systems involved in central appetite regulation [3]

For companies engaged in compounding of GLP-1 drug products, the warnings signal a need to reassess labeling, advertising, and promotional strategies